Shuttle Pharmaceuticals Holdings, Inc.

Shuttle Pharmaceuticals Holdings, Inc. financial statements

Shuttle Pharmaceuticals Holdings, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 11.72M10-K
Cash and equivalentsUSD 334K10-Q
Total debtUSD 232.15KEODHD

Shuttle Pharmaceuticals Holdings, Inc. financials on 6ix · Shuttle Pharmaceuticals Holdings, Inc. on 6ix